Free tool
Oncology stocks
We cover 4 companies grouped under the Oncology theme. The median market value in the group is $8.11B. Across the group, the median move over the past trading day is +1.63%. Price change over the past year runs from −0.4% to +265.9% across the middle 80 percent of the group, with a median of +45.7%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
4 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| IPN.PA | Ipsen S.A. | $15.97B | Large cap | +40.80% |
| 0IJO.L | Exelixis, Inc. | $14.05B | Large cap | +50.53% |
| HCM.L | HUTCHMED (China) Limited | $2.16B | Mid cap | −18.08% |
| NANO.PA | Nanobiotix S.A. | $2.05B | Mid cap | +358.21% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.